Complete financial analysis of Global Medical REIT Inc. (GMRE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Global Medical REIT Inc., a leading company in the REIT – Healthcare Facilities industry within the Real Estate sector.
You may be interested
- WEIli Holdings Limited (2372.HK) Income Statement Analysis – Financial Results
- Conagra Brands, Inc. (CAG) Income Statement Analysis – Financial Results
- Inflection Point Acquisition Corp. (IPAX) Income Statement Analysis – Financial Results
- Nichidai Corporation (6467.T) Income Statement Analysis – Financial Results
- Wavestone SA (WAVE.PA) Income Statement Analysis – Financial Results
Global Medical REIT Inc. (GMRE)
About Global Medical REIT Inc.
Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 140.93M | 137.28M | 115.94M | 93.73M | 70.73M | 53.19M | 30.22M | 8.08M | 2.06M | 380.41K | 0.00 | 0.00 |
| Cost of Revenue | 86.22M | 25.19M | 15.49M | 10.87M | 5.96M | 3.72M | 1.86M | 1.43M | 1.02M | 360.00K | 0.00 | 0.00 |
| Gross Profit | 54.72M | 112.10M | 100.45M | 82.86M | 64.77M | 49.47M | 28.36M | 6.65M | 1.04M | 20.41K | 0.00 | 0.00 |
| Gross Profit Ratio | 38.82% | 81.65% | 86.64% | 88.41% | 91.58% | 93.01% | 93.85% | 82.25% | 50.54% | 5.36% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.15 | 0.17 | -0.03 | 0.14 | 0.27 | 0.00 | -0.77 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 16.85M | 16.55M | 16.45M | 29.96M | 12.80M | 9.96M | 8.61M | 5.73M | 865.14K | 604.87K | 45.34K | 50.11K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 16.85M | 16.55M | 16.45M | 29.96M | 12.80M | 9.96M | 8.61M | 5.73M | 865.14K | 604.87K | 45.34K | 50.11K |
| Other Expenses | 0.00 | 56.72M | 46.88M | 36.35M | 24.64M | 17.27M | 121.00K | 130.78K | 659.67K | 129.08K | 0.00 | 0.00 |
| Operating Expenses | 16.90M | 73.27M | 63.33M | 66.32M | 37.44M | 27.23M | 18.61M | 8.10M | 1.52M | 733.95K | 45.34K | 50.11K |
| Cost & Expenses | 103.11M | 98.46M | 78.82M | 77.18M | 43.40M | 30.95M | 20.47M | 8.10M | 1.52M | 733.95K | 45.34K | 50.11K |
| Interest Income | 0.00 | 25.23M | 19.70M | 18.68M | 17.47M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 30.89M | 25.23M | 19.70M | 18.68M | 17.47M | 14.98M | 7.44M | 4.14M | 1.52M | 298.66K | 0.00 | 0.00 |
| Depreciation & Amortization | 59.01M | 98.81M | 78.97M | 77.51M | 43.70M | 31.33M | 23.00M | 10.43M | 659.67K | 129.08K | 0.00 | 50.11K |
| EBITDA | 111.64M | 96.49M | 84.00M | 53.00M | 50.82M | 40.20M | 17.35M | 2.48M | 569.53K | -224.46K | -45.34K | 0.00 |
| EBITDA Ratio | 79.21% | 70.28% | 72.45% | 56.44% | 73.48% | 75.58% | 66.18% | 30.75% | 58.04% | -59.01% | 0.00% | 0.00% |
| Operating Income | 37.94M | 38.83M | 37.12M | 16.55M | 27.33M | 22.24M | 7.35M | -2.21M | -1.52M | -652.21K | -45.34K | -50.11K |
| Operating Income Ratio | 26.92% | 28.28% | 32.02% | 17.65% | 38.64% | 41.82% | 24.31% | -27.41% | -73.96% | -171.45% | 0.00% | 0.00% |
| Total Other Income/Expenses | -16.20M | -18.83M | -18.78M | -30.77M | -17.47M | -7.68M | -9.96M | -6.33M | -2.13M | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 21.73M | 20.00M | 18.34M | -2.50M | 9.59M | 14.56M | -87.00K | -6.35M | -1.61M | -652.21K | -45.34K | -50.11K |
| Income Before Tax Ratio | 15.42% | 14.57% | 15.82% | -2.67% | 13.56% | 27.37% | -0.29% | -78.64% | -78.06% | -171.45% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 25.23M | 20.42M | 18.11M | 17.83M | 1.07M | -49.00K | 4.27M | 1.52M | 597.33K | 0.00 | 50.11K |
| Net Income | 20.61M | -5.23M | -2.07M | -20.61M | -8.24M | 13.49M | -38.00K | -6.35M | -1.61M | -652.21K | -45.34K | -50.11K |
| Net Income Ratio | 14.63% | -3.81% | -1.79% | -21.98% | -11.65% | 25.36% | -0.13% | -78.64% | -78.06% | -171.45% | 0.00% | 0.00% |
| EPS | 0.23 | -0.08 | -0.03 | -0.45 | -0.24 | 0.61 | 0.00 | -0.68 | -6.44 | -13.49 | -2.32 | -2.51 |
| EPS Diluted | 0.23 | -0.08 | -0.03 | -0.45 | -0.24 | 0.61 | 0.00 | -0.68 | -6.44 | -13.49 | -2.32 | -2.51 |
| Weighted Avg Shares Out | 65.55M | 65.46M | 60.64M | 46.26M | 33.87M | 21.97M | 19.62M | 9.30M | 250.00K | 48.36K | 19.57K | 20.00K |
| Weighted Avg Shares Out (Dil) | 65.55M | 65.46M | 60.64M | 46.26M | 33.87M | 21.97M | 19.62M | 9.30M | 250.00K | 48.36K | 19.57K | 20.00K |
Global Medical REIT Reports Tax Treatment of 2023 Dividends
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, announced today...
Global Medical REIT Inc. Board Declares 2023 Fourth Quarter Common and Preferred Dividends
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, announced today...
Should You Buy Global Medical REIT (GMRE) After Golden Cross?
After reaching an important support level, Global Medical REIT Inc. (GMRE) could be a good stock pick from a technical perspective. GMRE recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day...
Mouse Traps: 8 High-Yielding REITs Risking Dividend Cuts
Overall, this is a good time to invest in REITs. The expected surge in REIT share prices will not benefit all REITs equally. There are always mousetrap REITs, even in the best of times. Dividend safety is crucial for REIT...
Lock In 9%+ REIT Yields Before They Disappear
Ready for some “next level” dividend thinking? We have a potential opportunity right now to buy five payers yielding up to 14.9% as the economy heads into recession.
Global Medical REIT: A Hold Despite Improving Performance
In Q3, 2023, GMRE delivered an improved performance with the underlying FFO finally breaking the momentum of a constant decline. The key reasons for the growth in FFO per share relative to Q2, 2023 lay in the embedded rent escalators...
Global Medical REIT Announces Third Quarter 2023 Financial Results
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, today announced...
Global Medical REIT Inc. Announces Dates for Third Quarter Earnings Release and Webcast
BETHESDA, Md.--(BUSINESS WIRE)--Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), a net-lease medical office real estate investment trust (REIT) that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems, announced today...
Global Medical: 7.7% Yielding Preferreds Are Expensive, A Look At Alternatives
Global Medical REIT Inc. has seen a decline in its fixed charge coverage and funds from operations due to interest rate hikes. The preferreds are of course safer than the common shares here and offer 7.7%. We show you why...
One Of The Greatest Moments To Switch To Active Investing In REITs
Passive investing is generally more suitable for retail investors due to lower costs, diversification, and no risk of underperforming the market. Yet, the U.S. equity REIT universe has lately opened attractive pockets of opportunity for active investors to cherry-pick specific...
Source: https://incomestatements.info
Category: Stock Reports